Adeno-associated viral (AAV) vectors based on serotype 5 are an efficient means to target dorsal root ganglia (DRG) to study gene function in the primary sensory neurons of the peripheral nervous system. In this study, we have developed a compact AAV dual promoter vector composed of the cytomegalovirus (CMV) and chicken beta-actin (CAG) promoters in a back-to-back configuration with a shared enhancer, and show efficient expression of two proteins simultaneously in DRG neurons. We demonstrate how this is useful for experiments on axonal regeneration, by co-expressing a gene of interest and an axonal marker. Using a farnesylated form of eGFP, which is actively transported along axons, we show superior long-distance labelling of axons of DRG n...
Adeno-associated viral (AAV) vectors are effective gene therapy delivery candidates, and the AAV-PhP...
In the vast majority of studies utilizing adeno-associated virus (AAV) in central nervous system app...
Thesis (Ph.D.)--University of Washington, 2015The development of novel therapies to treat diseases o...
Various types of tracers are available for use in axon regeneration, but they require an extra opera...
The identification of axon growth-promoting genes, and overexpression of these genes in central nerv...
Recombinant adeno-associated viral (AAV) vectors are one of the most promising therapeutic delivery ...
Recombinant adeno-associated virus (rAAV) vector-mediated gene transfer into genetically defined neu...
Visualization of neurons is indispensable for the investigation of neuronal circuits in the central ...
Adeno-associated viral vectors are widely used as vehicles for gene transfer to the nervous system. ...
Abstract Background Gene transfer to nociceptive neurons of the dorsal root ganglia (DRG) is a promi...
By homologous recombination, a first-generation adenovirus-based gene transfer vector, AdCMVax-1, wa...
Targeted expression of foreign genes to the peripheral nervous system is interesting for many applic...
Adeno-associated virus 6 (AAV6) has been proposed as a potential vector candidate for specific gene ...
Adeno-associated viral (AAV) vectors allow for site-specific and time-dependent genetic manipulation...
Schwann cells (SCs) in an injured peripheral nerve form pathways for regenerating axons. Although th...
Adeno-associated viral (AAV) vectors are effective gene therapy delivery candidates, and the AAV-PhP...
In the vast majority of studies utilizing adeno-associated virus (AAV) in central nervous system app...
Thesis (Ph.D.)--University of Washington, 2015The development of novel therapies to treat diseases o...
Various types of tracers are available for use in axon regeneration, but they require an extra opera...
The identification of axon growth-promoting genes, and overexpression of these genes in central nerv...
Recombinant adeno-associated viral (AAV) vectors are one of the most promising therapeutic delivery ...
Recombinant adeno-associated virus (rAAV) vector-mediated gene transfer into genetically defined neu...
Visualization of neurons is indispensable for the investigation of neuronal circuits in the central ...
Adeno-associated viral vectors are widely used as vehicles for gene transfer to the nervous system. ...
Abstract Background Gene transfer to nociceptive neurons of the dorsal root ganglia (DRG) is a promi...
By homologous recombination, a first-generation adenovirus-based gene transfer vector, AdCMVax-1, wa...
Targeted expression of foreign genes to the peripheral nervous system is interesting for many applic...
Adeno-associated virus 6 (AAV6) has been proposed as a potential vector candidate for specific gene ...
Adeno-associated viral (AAV) vectors allow for site-specific and time-dependent genetic manipulation...
Schwann cells (SCs) in an injured peripheral nerve form pathways for regenerating axons. Although th...
Adeno-associated viral (AAV) vectors are effective gene therapy delivery candidates, and the AAV-PhP...
In the vast majority of studies utilizing adeno-associated virus (AAV) in central nervous system app...
Thesis (Ph.D.)--University of Washington, 2015The development of novel therapies to treat diseases o...